Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |